Perbandingan Kadar 25-(OH)-Vitamin D3 pada Serum Kelompok Mioma Uteri dan Non-Mioma Uteri

Aria Prasetya Masoem, Tono Djuwantono, Mulyanusa A. Ritonga, Jusuf Sulaeman Effendi, Wiryawan Permadi, Tita Husnitawati Madjid

Abstract


Abstrak
Tujuan: Penelitian ini bertujuan untuk membandingkan perbedaan kadar 25-hidroksi-vitamin D3 pada serum kelompok mioma uteri dan non-mioma uteri.
Metode: Penelitian ini merupakan penelitian analitik observasional dengan rancangan komparatif cross sectional. Subjek penelitian adalah wanita usia reproduksi yang menjalani prosedur laparatomi/laparaskopi yang memenuhi kriteria inklusi penelitian (n=42). Subjek penelitian dibagi menjadi dua kelompok, yakni kelompok mioma uteri (n=21) dan non-mioma uteri (n=21). Pada kedua kelompok dilakukan pemeriksaan kadar serum 25-hidroksi-vitamin D3 kemudian diperiksa dengan metode Electro-chemiluminescence Immunoassay (ECLIA). Penelitian ini dilakukan di RSUP Dr. Hasan Sadikin Bandung pada bulan Juni−Agustus 2017.
Hasil: Hasil penelitian menunjukkan kadar 25-hidroksi-vitamin D3 rata-rata pada kelompok mioma uteri adalah 6,70 (3,29) ng/ml, sementara pada kelompok non-mioma uteri 10,34 (2,79) ng/ml. Perbedaan kadar rata-rata 25-hidroksi-vitamin D3 pada kedua kelompok tersebut bermakna dengan nilai p<0,001. Namun, tidak didapatkan korelasi antara kadar 25-hidroksi-vitamin D3 dengan berat massa mioma uteri.
Kesimpulan : Kadar 25-hidroksi-vitamin D3 pada kelompok mioma uteri lebih rendah dibandingkan dengan kelompok non-mioma uteri.

Key words: Mioma uteri, vitamin D,  25-hidroksi-vitamin D3




Abstract
Objective: The aim of this study was to determine if there is any significant difference between serum levels of 25-hydroxy-vitamin D3 of uterine fibroid group and non-uterine fibroid group.
Method: This was an observational analytic study with comparative cross-sectional method. Subjects were women in reproductive age who underwent laparotomy / laparoscopy procedures who met the study criteria (n=42). The subjects were divided into two groups, uterine fibroid group (n=21) and non-uterine fibroid (n=21). Measurement of serum 25-hydroxy-vitamin D3 was performed using Electro-chemiluminescence Immunoassay (ECLIA) method. The study was conducted at Dr. Hasan Sadikin hospital in June−August 2017.
Result: The results showed the mean level 25-hydroxy-vitamin D3 on uterine fibroid group was 6.70 (3.29) ng / ml and non-uterine fibroid group 10.34 (2.79) ng/ml. There was significant difference between serum level of 25-hydroxy-vitamin D3 in uterine fibroid group and non-uterine fibroid with p value <0.001. But, there was no correlation between serum level of 25-hydroxy-vitamin D3 content and the weight of uterine fibroid mass. Conclusions: Serum level of 25-hydroxy-vitamin D3 is lower in uterine fibroid group than non-uterine fibroid group.

Key words: Uterine fibroid, vitamin D, 25-hydroxy-vitamin D3


Full Text:

PDF

References


Ilma N, Tjahyadi D, Judistiani TD. The Relationship of Age, Parity and Body Mass Index as Risk Factors to the Incidence of Uterine Myoma in Dr. Hasan Sadikin General Hospital. Althea Medical Journal. 2015;2(3):409−13.

Bulun SE. Mechanism of Disease: Uterine fibroids. N Engl J Med. 2013;369:1344−55.

Walker CL, Stewart EA. Uterine fibroids: the elephant in the room. Science. 2005;308(5728):1589−92.

Halder SK, Osteen KG, Al-Hendy A. 1, 25-Dihydroxyvitamin D3 Reduces Extracellular Matrix-Associated Protein Expression in Human Uterine Fibroid Cells 1. Biol Reprod. 2013;89(6):Article 150, 1-13.

Holick MF. Vitamin D: a millenium perspective. Journal of cellular biochemistry. 2003;88(2):296-307.

Baird DD, Hill MC, Schectman JM, Hollis BW. Vitamin D and the risk of uterine fibroids. Epidemiology. 2013;24(3):447-53.

Bläuer M, Rovio PH, Ylikomi T, Heinonen PK. Vitamin D inhibits myometrial and leiomyoma cell proliferation in vitro. Fertility and sterility. 2009;91(5):1919−25.

Sabry M, Halder SK, Allah ASA, Roshdy E, Rajaratnam V, Al-Hendy A. Serum vitamin D3 level inversely correlates with uterine fibroid volume in different ethnic groups: a cross-sectional observational study. J Womens Health. 2013;5:93.

Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100−7.

Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Env Health Pers. 2003;111(8):1037.

Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril. 2007;87(4):725-36.

Schwartz SM, Marshall LM, Baird DD. Epidemiologic contributions to understanding the etiology of uterine leiomyomata. Env Health Pers. 2000:821−7.

Ciavattini A, Di Giuseppe J, Stortoni P, Montik N, Giannubilo SR, Litta P, dkk. Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction. Int Obstet Gynecol. 2013;2013.

Baird DD, Hill MC, Schectman JM, Hollis BW. Vitamin D and Risk of Uterine Fibroids. Epidemiology (Cambridge, Mass). 2013;24(3):447.

Paffoni A, Somigliana E, Vigano’ P, Benaglia L, Cardellicchio L, Pagliardini L, dkk. Vitamin D status in women with uterine leiomyomas. The Journal of Clinical Endocrinology & Metabolism. 2013;98(8):E1374−E8.

Sabry M, Halder SK, Allah ASA, Roshdy E, Rajaratnam V, Al-Hendy A. Serum vitamin D3 level inversely correlates with uterine fibroid volume in different ethnic groups: a cross-sectional observational study. International journal of women’s health. 2013;5:93.

Mackawy AMH, Al-ayed BM, Al-rashidi BM. Vitamin D deficiency and its association with thyroid disease. International Journal of Health Sciences. 2013;7(No. 3).

Hilger J, Friedel A, Herr R, Rausch T, Roos F, Wahl DA, dkk. A systematic review of vitamin D status in populations worldwide. Brit J Nutrition. 2014;111(1):23−45.

Yosephine B, Khomsan A, Briawan D, Rimbawan. Peranan ultraviolet B sinar matahari terhadap status vitamin D dan tekanan darah pada wanita usia subur. Jurnal Kesehatan Masyarakat Nasional. 2014;8(No. 6).

Halder SK, Goodwin JS, Al-Hendy A. 1, 25-Dihydroxyvitamin D3 reduces TGF-β3-induced fibrosis-related gene expression in human uterine leiomyoma cells. The Journal of Clinical Endocrinology & Metabolism. 2011;96(4):E754−E62.

Ciavattini A, Carpini GD, Serri M, Vignini A, Sabbatinelli J, Tozzi A, dkk. Hypovitaminosis D and “small burden” uterine fibroids: Opportunity for a vitamin D supplementation. Medicine. 2016;95(52).

Wei J-J, Chiriboga L, Mittal K. Expression profile of the tumorigenic factors associated with tumor size and sex steroid hormone status in uterine leiomyomata. Fertil Steril. 2005;84(2):474−84.

Halder SK, Sharan C, Al-Hendy A. 1, 25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model. Biology of reproduction. 2012;86(4):116, 1−10.

Halder SK, Osteen KG, Al-Hendy A. Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and-9 in human uterine fibroid cells. Human reproduction. 2013;28(9):2407−16.

Halder SK, Osteen KG, Al-Hendy A. 1, 25-dihydroxyvitamin d3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells. Biology of reproduction. 2013;89(6):150, 1−13.




DOI: http://dx.doi.org/10.24198/obgynia.v2n1.65

Refbacks

  • There are currently no refbacks.


Alamat Redaksi

 

KSM/Dep Obstetri & Ginekologi Fakultas Kedokteran Universitas Padjadjaran RSUP Dr. Hasan Sadikin

Jl. Pasteur No 38 Bandung 40161 

Telp: 0813-2012-9954

Email: obgyniajurnal@gmail.com

 

 

 




Indexed By
         



Web Analytics
View My Stats

Indonesian Journal of Obstetrics & Gynecology Science @2017